Sab Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.11

+0.02 (+0.49%)

As of May 16, 2:06 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +664.2% upside

Low Target $26.29

Average Target $31.41

High Target $48.84

Current Price $4.11

Current
$4.11

Target
$31.41

$26.29 $31.41 avg $48.84

Scenario Analysis

Bear Case

$26.29

539.7%

Low target

Base Case

$31.41

+664.2%

Avg target

Bull Case

$48.84

+1,088.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$6.60

-37.7% from high

52-Week Low

$1.60

+156.9% from low

Target vs 52W High

$31.41

+375.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%